Health Care • Industrial Specialties
$1.84 ▼ -0.02
(-1.07%)
MKT CAP: $14.1M • VOL: 25.7K
52W L $1 52W H $15
CUPR // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 |
|---|---|---|
| Revenue (Total Sales) | $38.8K | $35.5K |
| YoY Revenue Growth % | +9.2% | — |
| Gross Profit | -$501 | -$2.2K |
| Gross Margin % | -1.3% | -6.3% |
| Research & Development (R&D) | — | — |
| Operating Income (EBIT) | -$3.8M | -$1.2M |
| Operating Margin % | -80.0% | -80.0% |
| Net Income (GAAP) | -$3.6M | -$1.1M |
| EBITDA (Normalized) | -$3.7M | -$1.2M |
| Diluted EPS ($/sh) | — | — |
| Operating Cash Flow (OCF) | -$7.1M | -$908.6K |
| Capital Expenditures (CapEx) | $45.3K | $16.1K |
| Free Cash Flow (FCF) | -$7.1M | -$924.7K |
| FCF Margin % | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% |
| Cash & Short-Term Equivalents | $2.4M | $85.6K |
| Total Debt (Short + Long Term) | $98.1K | $120.4K |
| Total Stockholders' Equity | $3.9M | -$3.3M |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR CUPR.